Less than two weeks after posting a scathing Form 483 filing, the FDA slammed Chinese API maker Sichuan Deebio Pharmaceuticals with a warning letter (PDF) citing “significant deviations” in its ...
China, the world leader in the API industry, is on a consolidation path and quality drive to raise its own benchmarks in the global turf, that too with no qualms about the tightening quality norms ...
The Active Pharmaceutical Ingredient (API) is the most important part of any drug. The API, as the name would suggest, is the chemical part of any capsule or tablet that works on the disease condition ...
BEIJING (Reuters) -Chinese artificial intelligence (AI) companies are moving swiftly to attract users of OpenAI's technology, following reports the U.S. firm plans to restrict access in China and ...
Chinese AI firms try to win over OpenAI users with special offers as ChatGPT maker restricts API use
Every Wednesday and Friday, TechNode’s Briefing newsletter delivers a roundup of the most important news in China tech, straight to your inbox. Sign up China’s AI companies are rushing to win over ...
OpenAI recently surprised users by announcing that, starting July 9, 2024, it will cease providing API services to China and other regions, including Hong Kong. This abrupt decision spells trouble for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results